SEC Form 4 · accession 0001562180-15-000971
Eledon Pharmaceuticals, Inc. · ELDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Buckley Jr.
Director
Period of report
Nov 11, 2015
Accepted (ET)
Nov 12, 2015 · 9:06 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001404281
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 11, 2015 | P | 3,000 | $11.25 | A | 3,000 | D |
Table II — derivative securities
No Table II lines on this filing.